최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0643974 (2009-12-21) |
등록번호 | US-8177716 (2012-05-15) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 4 인용 특허 : 1593 |
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
1. An analyte monitoring system, comprising: an analyte sensor;a housing;a telephone interface;a processor operatively coupled to the housing and in communication with the telephone interface, the processor configured to receive one or more analyte related signals from the analyte sensor and to dete
1. An analyte monitoring system, comprising: an analyte sensor;a housing;a telephone interface;a processor operatively coupled to the housing and in communication with the telephone interface, the processor configured to receive one or more analyte related signals from the analyte sensor and to determine an acceleration of the rate in the increase or decrease in the monitored analyte level based on the received one or more analyte related signals from the analyte sensor;an output unit coupled to the housing and in signal communication with the processor, the output unit configured to output information associated with analyte related signals; anda drug administration system configured to receive a drug administration protocol from the processor; wherein when a physiological condition is detected, the processor is configured to analyze the received one or more analyte related signals to predict an occurrence of a future episode associated with the physiological condition; andwherein the processor is trainable to modify the drug administration protocol based on the predicted occurrence of the future episode associated with the physiological condition. 2. The system of claim 1 wherein the analyte sensor includes a glucose sensor. 3. The system of claim 1 wherein the processor is configured to transmit the received one or more analyte related signals to the drug administration system. 4. The system of claim 1 wherein the processor is configured to receive the one or more analyte related signals from a transmitter coupled to the analyte sensor. 5. The system of claim 4 wherein the transmitter includes a radio frequency (RF) transmitter. 6. The system of claim 1 wherein the analyte sensor is transcutaneously positioned in fluid contact with an interstitial fluid under a skin layer. 7. The system of claim 1 including an in vitro glucose monitor coupled to the housing and configured to generate a signal based on a fluid sample associated with an analyte concentration. 8. The system of claim 7 wherein the in vitro glucose monitor includes a strip port coupled to the housing for receiving a test strip. 9. The system of claim 7 wherein the processor is configured to generate one or more information associated with the generated signal from the in vitro glucose monitor. 10. The system of claim 7 wherein the fluid sample includes a blood sample. 11. The system of claim 7 wherein the generated signal includes a calibration data. 12. The system of claim 11 wherein the analyte related signals from the analyte sensor are calibrated based at least in part on the generated signal. 13. The system of claim 1 wherein information associated with the received analyte related signals includes glucose level information. 14. The system of claim 13 wherein the processor is configured to determine the drug administration protocol based at least in part on the information associated with the received analyte related signals. 15. The system of claim 1 including one or more of a transmitter or a transceiver operatively coupled to the processor for communication with the drug administration system. 16. The system of claim 1 wherein the drug administration system includes one or more of an external infusion pump, an internal infusion pump, a syringe injector, a transdermal delivery system, or an inhalation system. 17. The system of claim 15 wherein the one or more of the transmitter or the transceiver is configured to transmit the one or more signals associated with the generated signal to the drug administration system using one or more of a radio frequency (RF) communication or an infrared communication. 18. The system of claim 1 wherein the output information on the output unit includes one or more of a visual output, an audible output, or a vibratory output. 19. The system of claim 18 wherein the visual output includes one or more of a graphical output, a text output, or a numerical output. 20. The system of claim 1 wherein the output unit includes a display unit. 21. The system of claim 1 wherein the physiological condition includes one of a hypoglycemic condition, a hyperglycemic condition, an impending hypoglycemic condition, or an impending hyperglycemic condition. 22. The system of claim 1 wherein the processor is configured to determine one or more patterns associated with the detected physiological condition, and further wherein predicting the occurrence of a future episode associated with the physiological condition is based at least in part on the determined one or more patterns.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.